Agebox iKids-Growth Recalled Over Undeclared Ibutamoren
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
Immediate attention
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
AGEBOX Inc. recalled 665 bottles of iKids-Growth capsules on October 28, 2025, due to undeclared ibutamoren. The product was marketed without an approved NDA/ANDA. Consumers should stop using the product immediately and contact Agebox for guidance.
Medline recalled 4.4 million Quick Strip Plastic Sterile Adhesive Bandages on October 27, 2025. The recall affects all lots due to potential open seals compromising sterility. Consumers and healthcare providers should stop using these bandages immediately.
Medline Industries recalled 11,291,800 units of Quick Strip Fabric Sterile Adhesive Bandages on October 27, 2025. The recall affects all lots due to potential open seals that compromise sterility. Consumers should stop using these bandages immediately.
Screw may loosen or fallout of Hemodialysis system
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Failed stability specifications: Out of specification for hardness test
Cipla USA recalled 1,180 boxes of Lanthanum Carbonate chewable tablets on October 24, 2025. The recall follows a failure to meet stability specifications for hardness tests. Consumers and healthcare providers must stop using the product immediately.
As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
EDAN recalled 379 patient monitors on October 24, 2025, due to potential cybersecurity issues. Models iX10, iX12, and iX15 pose risks to patient safety. Healthcare providers should stop using these devices immediately.